Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001005794-05-000459

Options or other derivatives

  • Chief Executive Officer acquired 325,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DEES H CRAIG · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2005-05-19 Grant or award : show line 1 in the form Nonqualified Stock Option (right to buy) +25,000 $0.62 2015-05-19 25,000 25,000 D
2005-05-25 Grant or award : show line 2 in the form Nonqualified Stock Option (right to buy) +300,000 $0.58 2015-05-25 300,000 300,000 D
Loading xslF345X02/primary_doc.xml…